Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2020

Dec 3, 2020

29745_dirs_2020-12-02_dd1c8b38-91af-4adb-af86-4c746b99ddc3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2020-12-01

Reporting Person: Zakrowski Donald A (Chief Accounting Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-01 Restricted Stock Unit $ A 4810 Acquired 2023-12-01 Common Stock (4810.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4740 Direct
Common Stock 1656 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.